Author

J. Schlom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. J. Martins· 1 shared A. Mammen· 1 shared A. Rajan· 1 shared C. Allen· 1 shared C. Van Waes· 1 shared C. Zhao· 1 shared H. Abdul Sater· 1 shared I. Pinal-Fernandez· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. J. Martins

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Contrasting autoimmune and treatment effects reveals baseline set points of immune toxicity following checkpoint inhibitor treatment

C. Zhao, M. P. Mule, A. J. Martins, I. Pinal-Fernandez, R. N. Donahue, J. Chen, J. Schlom, J. L. Gulley, A. Mammen, J. S. Tsang, A. Rajan

The paper identifies pre-treatment immune signatures associated with immune-related adverse events (irAEs) in thymic cancer patients receiving checkpoint inhibitors using CITE-seq.

bioRxiv · Jun 5, 2022 · PreprintImmunology

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

Y. Robbins, S. Greene, J. Friedman, P. E. Clavijo, C. Van Waes, K. P. Fabian, M. R. Padget, H. Abdul Sater, J. H. Lee, P. Soon-Shiong, J. Gulley, J. Schlom, J. Hodge, C. Allen

This study shows PD-L1 CAR-engineered NK cells kill cancer cells and inhibit tumor growth by targeting PD-L1, reducing myeloid cells in both preclinical models and patient blood.

bioRxiv · Jan 30, 2020Immunology